{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-146980","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2023-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.998033+00:00","generated_at":"2026-06-14T22:26:37.299696+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Prelude Therapeutics files updated investor presentation; no material new data disclosed","bullets":["Company filed an updated corporate presentation dated May 2023 as Exhibit 99.1 to Form 8-K.","Presentation intended for use in investor meetings; contains no specific financial results or guidance changes.","No new business developments, clinical data, or strategic announcements included in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-146980","json":"https://secwatch.observer/filing/0001193125-23-146980.json","markdown":"https://secwatch.observer/filing/0001193125-23-146980.md","text":"https://secwatch.observer/filing/0001193125-23-146980.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000119312523146980/0001193125-23-146980-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000119312523146980/d488347d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T22:26:37.299696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}